Literature DB >> 10445539

p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.

B Zhao1, W Kimura, N Futakawa, T Muto, K Kubota, Y Harihara, T Takayama, M Makuuchi.   

Abstract

OBJECTIVE: There have been few studies on the molecular biological characteristics of carcinoma of the papilla of Vater. In this study, p53 and p21/Waf1 expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater were investigated.
METHODS: Thirty-seven cases of carcinoma of the papilla of Vater were studied. Macroscopically, the carcinoma was ulcerative in 15 cases and nonulcerative in 22 cases. Histologically, nine were intestinal type, 27 were pancreaticobiliary type, and one was undifferentiated. Formalin-fixed, paraffin-embedded sections were immunohistochemically stained for p53 and p21. K-ras codon 12 mutation was detected with the two-step polymerase chain reaction-restriction fragment length polymorphism method, followed by direct sequencing.
RESULTS: p53 overexpression was found in 17 of 37 cases (46%) and was more frequent in the ulcerative type than in the nonulcerative type (67% vs 32%, p < 0.05). p21/Waf1 protein expression was found in 15 of 37 cases (41%), and was not correlated with that of p53. K-ras codon 12 mutation was found in 14 of 37 cases (38%), and was more frequently detected in the intestinal type than in the pancreaticobiliary type (66% vs 30%, p < 0.05). On direct sequencing, the mutations were mainly GGT to GAT (9/14) and GGT to GTT (4/14). The type of mutation did not correlate with the histological type.
CONCLUSIONS: In carcinoma of the papilla of Vater, p53 overexpression may play a role in tumor ulceration. p21/Waf1 expression is induced via a p53-independent pathway. Carcinomas of the intestinal and pancreaticobiliary types may develop via different mechanisms, and K-ras mutation is mainly associated with the intestinal type.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445539     DOI: 10.1111/j.1572-0241.1999.01309.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Histological evaluation of preoperative biopsies from ampulla vateri.

Authors:  Gábor Elek; Sándor Gyôri; Bernadett Tóth; Akos Pap
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

2.  COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters.

Authors:  Giuseppe Perrone; Daniele Santini; Mariagiovanna Zagami; Bruno Vincenzi; Alfio Verzì; Sergio Morini; Domenico Borzomati; Roberto Coppola; Armando Antinori; Paolo Magistrelli; Giuseppe Tonini; Carla Rabitti
Journal:  Virchows Arch       Date:  2006-08-12       Impact factor: 4.064

3.  K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Shin-Ichirou Horiguchi; Yukiko Hayashi; Xiaoqing Yun; Toshikazu Yamaguchi; Koji Tsuruta; Tsuneo Sasaki
Journal:  J Gastroenterol       Date:  2010-02-16       Impact factor: 7.527

Review 4.  [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings].

Authors:  H-P Fischer; H Zhou
Journal:  Pathologe       Date:  2003-04-09       Impact factor: 1.011

Review 5.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

6.  Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study.

Authors:  M Svrcek; F Jourdan; N Sebbagh; A Couvelard; D Chatelain; N Mourra; S Olschwang; D Wendum; J-F Fléjou
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

7.  Increased cyclin D1 expression in cancer of the ampulla of Vater: relevance to nuclear beta catenin accumulation and k-ras gene mutation.

Authors:  K Yamazaki; K Hanami; T Nagao; A Asoh; I Sugano; Y Ishida
Journal:  Mol Pathol       Date:  2003-12

8.  Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.

Authors:  G Perrone; S Morini; D Santini; C Rabitti; B Vincenzi; R Alloni; A Antinori; P Magistrelli; R Lai; C Cass; J R Mackey; R Coppola; G Tonini; A Onetti Muda
Journal:  Eur J Histochem       Date:  2010       Impact factor: 3.188

9.  Significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in carcinoma of the papilla of Vater.

Authors:  B Zhao; W Kimura; N Futakawa; H Abe; J Kitayama; H Nagawa; M Makuuchi
Journal:  Jpn J Cancer Res       Date:  2000-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.